Cancer Institute of New Jersey (CINJ)

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ) is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

    • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Robert Aiken

    Robert Aiken

    Person

    19782019
    No photo of Joseph Aisner

    Joseph Aisner

    Person

    19742024
    No photo of Brandon Alderman

    Brandon Alderman

    Person

    20032020

    Projects

    Impact of mutation burden on cancer growth and the immune landscape

    Ganesan, S., Lattime, E. & White, E.

    National Institutes of Health

    12/1/19 → 11/30/24

    Project: Research project

    • ENDOGENOUS RETROVIRUS EXPRESSION, CHROMATIN ABNORMALITIES, AND RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN CLEAR CELL RENAL CELL CANCER

    Ganesan, S.

    Congressionally Directed Medical Research Programs (CDMRP)

    9/30/19 → 9/29/21

    Project: Research project

    • Rutgers Optimizes Innovation (ROI) Program

    Libutti, S., Kohn, J., Panettieri, R. & Pasqualini, R.

    National Institutes of Health

    9/23/19 → 8/31/23

    Project: Research project

    • Research Output

    18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab

    Lim, I., Lindenberg, M. L., Mena, E., Verdini, N., Shih, J. H., Mayfield, C., Thompson, R., Lin, J., Vega, A., Mallek, M., Cadena, J., Diaz, C., Mortazavi, A., Knopp, M., Wright, C., Stein, M., Pal, S., Choyke, P. L. & Apolo, A. B., Jan 1 2020, In : European Journal of Nuclear Medicine and Molecular Imaging. 47, 1, p. 178-184 7 p.

    Research output: Contribution to journal › Article

    Open Access

    • ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

    Pearson, A. D. J., Rossig, C., Lesa, G., Diede, S. J., Weiner, S., Anderson, J., Gray, J., Geoerger, B., Minard-Colin, V., Marshall, L. V., Smith, M., Sondel, P., Bajars, M., Baldazzi, C., Barry, E., Blackman, S., Blanc, P., Capdeville, R., Caron, H., Cole, P. D. & 25 others, Jiménez, J. C., Demolis, P., Donoghue, M., Elgadi, M., Gajewski, T., Galluzzo, S., Ilaria, R., Jenkner, A., Karres, D., Kieran, M., Ligas, F., Lowy, I., Meyers, M., Oprea, C., Peddareddigari, V. G. R., Sterba, J., Stockman, P. K., Suenaert, P., Tabori, U., van Tilburg, C., Yancey, T., Weigel, B., Norga, K., Reaman, G. & Vassal, G., Mar 2020, In : European Journal of Cancer. 127, p. 52-66 15 p.

    Research output: Contribution to journal › Article

    Open Access

    • Activation of ATR-related protein kinase upon DNA damage recognition

    Ma, M., Rodriguez, A. & Sugimoto, K., Apr 1 2020, In : Current Genetics. 66, 2, p. 327-333 7 p.

    Research output: Contribution to journal › Review article